LYTTON LAURENCE W 13D and 13G filings for DiaMedica Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-15 2:25 pm Sale | 2021-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC | LYTTON LAURENCE W | 1,071,970 4.100% | -308,296![]() (-22.34%) | Filing |
| 2021-10-06 4:19 pm Purchase | 2021-09-26 | 13G | DiaMedica Therapeutics Inc. DMAC | LYTTON LAURENCE W | 1,380,266 5.200% | 1,380,266![]() (New Position) | Filing |

